The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population

• Published in: Hereditary cancer in clinical practice Vol. 13; no. 1; p. 8
• Main Authors: Kaczmarek-Ryś, Marta, Ziemnicka, Katarzyna, Hryhorowicz, Szymon T, Górczak, Katarzyna, Hoppe-Gołębiewska, Justyna, Skrzypczak-Zielińska, Marzena, Tomys, Michalina, Gołąb, Monika, Szkudlarek, Malgorzata, Budny, Bartłomiej, Siatkowski, Idzi, Gut, Paweł, Ruchała, Marek, Słomski, Ryszard, Pławski, Andrzej
• Format: Journal Article
• Language: English
• Published: Poland BioMed Central Ltd 01.03.2015; BioMed Central
• Subjects: Cancer; Carcinoma; Development and progression; Genetic aspects; Health aspects; Metastasis; Prognosis; Risk factors; Thyroid cancer; Thyroid gland; Poland; Cancer risk factors; Differentiated thyroid carcinoma; CHEK2 gene sequence variants; Genotyping
• ISSN: 1731-2302; 1897-4287; 1897-4287
• DOI: 10.1186/s13053-015-0030-5

Differentiated thyroid carcinoma (DTC) originates from thyroid follicular epithelial cells and belongs to a group of slowly progressing tumors with a relatively good prognosis. However, recurrences and metastases are a serious problem in advanced stages. Furthermore, progression from a well differentiated thyroid carcinoma to an aggressive anaplastic one is possible. The majority of differentiated thyroid carcinomas are sporadic but a few alleles increasing the cancer risk are known. One of them is the c.470 T > C (p.I157T, rs17879961) missense substitution in the CHEK2 gene. The aim of this study was to investigate whether this specific CHEK2 alteration, c.470 T > C, predisposes the Great Poland (Wielkopolska) population to thyroid cancer. 602 differentiated thyroid carcinoma patients and 829 controls randomly selected from population were genotyped for the presence of the c.470C allele using pyrosequencing. Hardy-Weinberg Equilibrium (HWE) was tested for both groups by chi-square distribution and Fisher's exact test. The odds ratios (ORs), 95% confidence intervals (CIs), and p-values were calculated using the R software. The results of genotyping showed the presence of the c.470C allele in 51 patients with a frequency of 4.49%, while in a controls in 42 patients with a frequency of 2.53%. We demonstrated that in the Great Poland population the c.470C CHEK2 variant increases the risk of developing differentiated thyroid cancer almost twice (OR = 1.81, p = 0.004). The risk of papillary thyroid carcinoma in female patients homozygous for the c.470C allele was shown to increase almost 13-fold (OR = 12.81, p = 0.019). Identification of c.470C CHEK2 gene variant ought to be taken into account by healthcare policymakers. Future well-designed and larger population studies are of great value in confirming these findings. Moreover, a combination of genetic factors together with environmental exposures should also be considered.